✨
AI Summary
- Anixa Biosciences CEO Amit Kumar details progress on a CAR-T therapy for ovarian cancer.
- The program serves as proof of concept for solid tumor indications.
- The approach leverages hormone/hormone receptor relationships for targeted treatment.
Guests on This Episode
AP
Amit Kumar, Ph.D
1 podcast appearance